Insulin therapy for adult patients with type 2 diabetes mellitus: a position statement of the Korean Diabetes Association, 2017
The Korean Journal of Internal Medicine
;
: 967-973, 2017.
Article
in English
| WPRIM
| ID: wpr-67289
ABSTRACT
The Korean Diabetes Association (KDA) has regularly updated its Clinical Practice Guidelines. In 2017, the KDA published a position statement on the use of antihyperglycemic agents for patients with type 2 diabetes mellitus (T2DM). Growing evidence from new multinational clinical trials using novel and traditional insulin analogues has also been accumulated. Following global trends, many results of clinical trials, especially concerning the clinical efficacy and safety of insulin therapy, have been published about Korean patients with T2DM. After a systematic search of recent evidence, the KDA updated and modified its clinical practice recommendations regarding the initiation, choice, and intensification of insulin and created an insulin treatment algorithm for the first time to guide physicians caring for adult Korean patients with T2DM.
Full text:
Available
Index:
WPRIM (Western Pacific)
Main subject:
Treatment Outcome
/
Diabetes Mellitus, Type 2
/
Hypoglycemic Agents
/
Insulin
/
Korea
Type of study:
Practice guideline
Limits:
Adult
/
Humans
Country/Region as subject:
Asia
Language:
English
Journal:
The Korean Journal of Internal Medicine
Year:
2017
Type:
Article
Similar
MEDLINE
...
LILACS
LIS